Target
Treatment / Non-Surgical
Hand Rejuvenation with Filler
A focused treatment page built around indication, mechanism, expected experience and realistic limits.
Treatment snapshot
These are orientation points, not promises. Timing and suitability depend on the treatment, anatomy and individual response.
Mechanism
Which method matches the underlying issue?
Plan
What intensity, timing and follow-up make sense?
Hands often reveal age for a different reason than the face does.
The problem is not usually that one line has become deep enough to fill.
With time, the soft-tissue layer over the back of the hand becomes thinner. Veins that were always present become more visible. Extensor tendons become easier to see during movement. Metacarpal contours can look more skeletal. At the same time, the skin itself develops sun-related pigmentation, texture change and laxity.
These mechanisms can all be described by the patient as “old hands”.
They do not all respond to filler.
This is why I do not begin by deciding how much product should be placed between the tendons.
I begin by separating the problem: is the hand looking older because the soft-tissue cover has become thin, because the skin itself is photodamaged, because veins are prominent, or because several of these changes are present together?
Filler is particularly good at one of those jobs.
Restoring the lost soft-tissue envelope.
Visible veins are often evidence of lost coverage rather than abnormal veins
The veins on the back of the hand are normal anatomy.
They become more visible when the tissue covering them becomes thin.
This distinction is important because hand filler does not remove the veins.
It adds volume in a tissue plane above them so that the contours underneath become less visually dominant.
The same principle applies to visible extensor tendons and bony prominences.
The treatment is therefore not vascular therapy.
Hand filler does not erase veins.
It restores part of the soft-tissue layer that used to make those veins less visible.
That is a much more accurate explanation of what the result represents.
The ageing hand contains both intrinsic ageing and accumulated sun exposure
Loss of subcutaneous volume is largely a structural ageing issue.
Brown spots, mottled pigmentation, roughness and some textural changes are strongly influenced by cumulative ultraviolet exposure.
A filler can improve the first mechanism.
It does not bleach a solar lentigo.
This is why a hand can look significantly better after volume restoration and still retain obvious sunspots.
Conversely, treating pigmentation alone can leave the hand bright but skeletal.
Neither treatment has failed.
The hand contained two separate ageing mechanisms.
I assess the hand in movement as well as at rest
The back of the hand is dynamic.
Tendons move with finger extension and flexion. Veins change prominence with position and temperature. Skin folds differently when the hand closes.
A filler result therefore has to work while the hand is being used.
A perfectly smooth photograph with the hand relaxed on a table is not enough.
If product collects into visible ridges during movement or obscures normal anatomical transitions unnaturally, the correction has become too obvious.
I want volume restoration that softens the skeletal appearance without making the hand look padded.
The goal is not to make an adult hand look like a child’s hand
Normal hands have veins and tendons.
Completely erasing those structures would require progressively increasing volume and would create a new kind of abnormality.
The aesthetic endpoint is softer visibility.
The patient should still have a hand.
Not an inflated surface in which normal anatomy has been hidden at all costs.
I want the hand to look less depleted, not anatomically blank.
This is one of the regions in which a little residual skeletal definition often looks much more natural than complete correction.
The dorsal hand has specific tissue planes that make placement important
The back of the hand contains skin, superficial soft-tissue layers, veins, sensory structures, extensor tendons and deeper anatomy arranged within relatively little thickness.
Contemporary anatomical approaches describe a superficial lamina that contains relatively few major vessels and nerves compared with deeper planes.
This is one reason appropriately selected superficial placement can provide useful coverage while keeping product away from more vulnerable structures.
But “safe plane” should not be interpreted as anatomy-free treatment.
The hand is thin.
An injection placed too superficially can be visible. One placed too deeply can interact with tendons, vessels and other structures that the treatment was never intended to affect.
Filler should spread as a layer rather than behave as a collection of lumps
Facial filler can sometimes be used deliberately to create focal projection.
The dorsal hand usually needs another type of result.
I am not trying to build one point.
I am restoring a relatively broad soft-tissue sheet.
This means product distribution matters enormously.
A narrow ridge or isolated bolus can remain visible under thin hand skin. A smoother homogeneous distribution better recreates the tissue that has been lost.
This is why massage or product moulding is part of some hand-filler techniques, depending on the filler used.
The material has to behave like coverage rather than sculpture.
Hyaluronic acid and calcium hydroxylapatite have different advantages
Both HA and CaHA are well-established hand-rejuvenation filler categories.
They should not be treated as interchangeable simply because both restore volume.
Hyaluronic acid provides immediate soft-tissue volume and can be selected in formulations designed to integrate smoothly within mobile superficial tissue.
A practical advantage is reversibility: HA can be reduced with hyaluronidase when clinically appropriate.
Calcium hydroxylapatite also provides immediate correction but has different rheological and biological properties. Over time, its carrier gel is resorbed while the CaHA microspheres can stimulate collagen-related tissue response.
The choice should follow the degree of volume deficit, tissue thickness, desired material behaviour and the importance of reversibility for the particular patient.
CaHA is not simply a longer-lasting version of HA
This distinction is useful.
CaHA is a particulate filler with a different structure from an HA gel.
Its correction comes from immediate volume together with subsequent biostimulatory effects.
It cannot be enzymatically dissolved with hyaluronidase.
This means placement has to be especially deliberate.
If an HA result is aesthetically excessive, reducing the material is often possible.
With CaHA, correction of an unwanted contour may require time or other management rather than a simple dissolving injection.
Longevity is only an advantage when the placement deserves to last.
I do not choose a material simply because it stays longer.
A hybrid filler can combine material properties without eliminating either material’s limitations
Recent hand-rejuvenation literature has explored mixtures or hybrid formulations containing HA and CaHA.
The logic is understandable.
HA can provide smooth immediate hydration and integration while CaHA contributes structural and biostimulatory characteristics.
Early studies are encouraging.
But the combination does not create a filler with every advantage and no trade-off.
Once CaHA is part of the material, complete enzymatic reversibility is no longer equivalent to pure HA.
The formulation and technique therefore still matter.
The amount of filler should be determined by visible deficit rather than by the size of the syringe
Hands differ significantly in baseline thickness.
A lean patient with marked tendon and metacarpal visibility may require more restoration than someone with mild early volume loss.
But there is also a ceiling.
The purpose is not to use enough filler to make every contour disappear.
Especially in a small hand, a standard amount can be too much.
I prefer to treat until the underlying structures become less dominant and then stop.
Unused product is not evidence that treatment was incomplete.
Hand dominance can create real asymmetry
The two hands are not necessarily identical.
Muscle use, veins, previous trauma, occupational exposure and sun exposure can differ.
The dominant hand may show different soft-tissue characteristics from the non-dominant one.
This means equal product volume on both sides is not automatically equal treatment.
Symmetry should come from the anatomy after treatment, not from distributing the syringe mathematically.
Volume loss and skin laxity overlap but filler cannot tighten everything
Adding volume beneath thin skin can improve the way that skin is supported.
This can make fine wrinkling and laxity look less obvious.
But significant skin redundancy is still a skin-envelope problem.
If the patient has primarily crepey or photodamaged skin with relatively adequate volume, another treatment mechanism may be more logical.
Energy-based treatment, resurfacing or selected biostimulatory approaches may have a role depending on the exact concern.
I do not want filler to expand until it becomes the answer to every sign of hand ageing.
Brown spots require a pigment strategy, not more filler
Solar lentigines are extremely common on the dorsal hands because of cumulative sun exposure.
They can remain prominent after an otherwise excellent filler result.
If pigmentation is an important part of the patient’s concern, pigment-specific laser, IPL/BBL or another appropriate treatment can be considered after diagnosis.
Again, the combination makes sense because the treatments have different jobs.
Volume treatment covers tendons and bones.
Light-based treatment addresses selected pigment.
Neither should receive credit for the other’s result.
Prominent veins themselves can be treated, but that is a separate vascular decision
Some patients remain bothered by large dorsal veins even after appropriate volume restoration.
Vascular treatment options exist, including selected sclerotherapy or other approaches.
That is not the same procedure as hand filler.
A vein should not be treated merely because it remains visible after filler if it is normal and the patient is satisfied with the overall hand.
If direct vein treatment is considered, venous anatomy and the functional importance of the hand circulation need their own assessment.
I prefer to avoid turning every visible anatomical structure into a separate cosmetic defect.
Filler-related swelling can temporarily make the hand look better than the final result
The hand can swell after injection.
Bruising is also possible because superficial vessels are abundant and visually prominent.
Early edema may temporarily hide tendons and veins more completely than the final filler volume will.
This can create an important expectation error.
When swelling resolves, some normal anatomy returns and the patient may believe the filler has disappeared.
I prefer to judge the true result after the acute tissue response has settled.
Early asymmetry should not automatically be corrected while tissue is swollen
One hand can bruise or swell more than the other.
A focal entry site can look fuller temporarily.
If I add more product immediately to the side that appears smaller, I may be treating edema rather than anatomy.
A small residual deficit can always be corrected later.
An overfilled hand is much harder to make look elegant.
Nodules and visible product are particularly obvious under thin dorsal skin
The hand has limited tissue available to camouflage irregular placement.
This makes product choice, dilution where appropriate, treatment plane and distribution important.
Small nodules can sometimes be massaged or managed conservatively depending on the filler and timing.
Persistent or inflammatory nodules need proper assessment rather than repeated manipulation.
With HA, hyaluronidase can provide a correction pathway when excess product itself is the problem.
With non-HA materials, the strategy is different.
Vascular complications are uncommon but the hand contains important vessels
The dorsal veins are obvious, but the hand also contains arteries and a complex vascular network.
Any filler injection carries some risk of unintended vascular entry or compression.
Appropriate superficial anatomical planes, slow controlled placement and continuous attention to tissue response reduce that risk.
I do not describe hand filler as risk-free simply because the major veins are visible and apparently easy to avoid.
Visible anatomy is only part of the vascular anatomy.
Functional symptoms after filler deserve immediate attention
Severe pain, unusual blanching or colour change, increasing swelling, sensory abnormality or impaired movement should not be dismissed as ordinary post-injection bruising.
The hand is a functional organ.
Aesthetic treatment should never allow concern about appearance to delay assessment of a possible vascular, infectious or inflammatory complication.
In the hand, function always outranks cosmetic perfection.
HA reversibility is valuable because the hand changes with movement
A filler may look acceptable in one static position but interfere visually with normal contours during finger movement.
With HA, the ability to reduce product gives us a meaningful correction option when excess volume or irregularity persists.
This is one reason reversibility can be particularly attractive for first-time treatment in thin, mobile anatomy.
But the availability of hyaluronidase should not be used as permission to overfill.
A carefully planned treatment remains preferable to a treatment designed around the assumption that it can later be undone.
Hand filler and facial filler should age independently
A patient may receive facial filler regularly and assume the hands should be maintained on the same schedule.
There is no reason for that.
Different anatomical areas experience different movement, product distribution and visible ageing.
I reassess the hands independently.
If adequate soft-tissue coverage remains, another treatment is not automatically required because the face is being treated that year.
Maintenance should replace recurrent deficit rather than accumulate material
The ageing process continues after hand filler.
The filler itself also changes over time.
A future top-up may be reasonable when tendon, vein and bone visibility has genuinely returned.
What I do not want is to repeat the original full volume every year without asking how much product and correction remain.
The risk of any maintenance programme is that restoration slowly becomes accumulation.
The hand is particularly unforgiving because excess material can make the dorsum look puffy and obscure normal movement.
Combination hand rejuvenation makes sense because the hand ages through several layers
A coherent treatment plan may combine volume restoration with pigment treatment or another skin-quality procedure.
That does not mean every patient needs a package.
A thirty-five-year-old with early tendon visibility but excellent skin may need only volume.
A sixty-year-old with relatively preserved volume but extensive solar lentigines may benefit much more from treating the skin.
The combination should follow the anatomy rather than the phrase hand rejuvenation.
What a good hand-filler result means to me
I want the dorsal hand to look less depleted.
Veins and tendons may still be visible, but they should no longer dominate the appearance. Bony transitions can become softer. The skin should move naturally over the restored tissue.
I do not want the hand completely smooth at rest and swollen-looking in motion.
I do not want filler to be used to hide pigmentation that requires another treatment.
And I do not want an adult hand to lose every anatomical feature associated with being an adult hand.
The best result restores coverage.
It does not erase anatomy.
When hand rejuvenation with filler makes sense to me
I am most comfortable recommending filler when volume loss is clearly responsible for prominent dorsal veins, tendons, bony contours or a generally skeletonised appearance.
HA and CaHA can both be reasonable materials in appropriately selected patients, with different trade-offs around integration, biostimulation and reversibility.
I become more cautious when the main concern is pigmentation, significant skin laxity or a vascular issue rather than lost soft-tissue volume.
I also favour restraint in very thin hands because every excess millilitre becomes visible quickly.
The hand does not need to look young by looking featureless.
It needs enough soft tissue that normal anatomy is framed rather than exposed.
Frequently asked questions
Why do hands look older with age?
Several mechanisms contribute, including loss of subcutaneous soft tissue, increased visibility of veins and tendons, skin thinning, wrinkles and cumulative sun-related pigmentation.
What does hand filler actually do?
It restores soft-tissue volume over the back of the hand, making underlying tendons, veins and bones less visually prominent.
Does hand filler remove veins?
No. The veins remain anatomically present. Filler restores some of the soft-tissue coverage above them so they become less obvious.
Which fillers can be used for hand rejuvenation?
Hyaluronic acid and calcium hydroxylapatite are among the best-established options. Their material properties and reversibility differ, so the choice should be individualised.
Is HA or CaHA better for hands?
Neither is universally better. HA offers smooth volume restoration and enzymatic reversibility. CaHA provides volume together with biostimulatory effects but cannot be dissolved with hyaluronidase.
Can hand filler improve wrinkles?
Restoring volume can make some fine wrinkling look less obvious by improving tissue support. Significant skin-quality or laxity concerns may require another treatment mechanism.
Does hand filler treat sunspots?
No. Brown sunspots are pigment problems. Laser or light-based treatment may be considered separately when those lesions are appropriately diagnosed.
Will the veins disappear completely?
I do not use complete disappearance as the endpoint. Some residual vein and tendon visibility is normal and often produces a more natural result.
Can hand filler look lumpy?
Yes, particularly if product is placed irregularly or too superficially in thin tissue. Appropriate product selection, treatment plane and broad distribution are important.
Can hand filler be dissolved?
Hyaluronic-acid filler can often be reduced with hyaluronidase. CaHA and other non-HA materials do not have the same enzymatic reversal pathway.
How long does hand filler last?
Duration depends on the material, amount used, tissue and individual biology. I prefer maintenance based on recurrent volume deficit rather than one fixed calendar.
Is hand filler safe?
Most reactions are temporary, such as swelling and bruising, but nodules, infection and vascular complications are possible. Detailed knowledge of dorsal hand anatomy and appropriate treatment plane are important.
Can hand filler be combined with BBL or laser?
Yes, when volume loss and pigment or skin-quality changes coexist. Each treatment should address its own mechanism and be sequenced appropriately.
When would you recommend no hand filler?
I would not use filler when adequate volume is already present, when pigmentation or skin laxity is the actual dominant concern, or when the additional volume required to hide normal anatomy would make the hand look puffy rather than rejuvenated.
Dr. Mert Demirel
Plastic, Reconstructive & Aesthetic Surgery
Anatomy first. Proportion over excess. Decisions built to remain coherent over time.
Next step
The best treatment is the one that matches the right indication.
You do not need to choose a device, injectable or technique before asking the question. Start with what you would like to improve.
Private consultation
Let’s start with your question.
Leave your number first. We can then continue privately on WhatsApp.
